Axis Physical Therapy Inc - Medicare Physical Therapist in Edmonds, WA

Axis Physical Therapy Inc is a medicare enrolled "Physical Therapist" provider in Edmonds, Washington. Their current practice location is 21009 76th Ave W, Edmonds, Washington. You can reach out to their office (for appointments etc.) via phone at (425) 672-2910.

Axis Physical Therapy Inc is licensed to practice in Washington (license number 602 606 543 1 1) and it also participates in the medicare program. Axis Physical Therapy Inc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1205864816.

Contact Information

Axis Physical Therapy Inc
21009 76th Ave W,
Edmonds, WA 98026-7126
(425) 672-2910
(425) 778-1872



Healthcare Provider's Profile

Full NameAxis Physical Therapy Inc
TypeFacility
SpecialityPhysical Therapist
Location21009 76th Ave W, Edmonds, Washington
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1205864816
  • Provider Enumeration Date: 06/30/2006
  • Last Update Date: 08/22/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 6901804210
  • Enrollment ID: O20061121000435

Medical Identifiers

Medical identifiers for Axis Physical Therapy Inc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1205864816NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225100000XPhysical Therapist 602 606 543 1 1 (Washington)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Axis Physical Therapy Inc acts as a billing entity for following providers:
Provider NameMelissa A Johnson
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1205971637
PECOS PAC ID: 1759377252
Enrollment ID: I20040421000987

News Archive

Study highlights health outcomes in Hispanic and Latino populations

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, released the largest and most comprehensive health and lifestyle analysis of people from a range of Hispanic/Latino origins. The data will enable individuals, communities, and policy makers to tailor better health intervention strategies.

OSU study finds that injury prevention programs are not being used in high schools

Injury prevention programs can help reduce ankle, knee and other lower extremity injuries in sports, but the programs are not being widely used in high schools, a new study from Oregon State University has found.

Ventrus prices initial public offering at $6.00 per share

Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced the pricing of its initial public offering of 2,900,000 shares at $6.00 per share. The shares are expected to begin trading tomorrow, December 17, 2010 on the Nasdaq Capital Market under the symbol "VTUS". In addition, Ventrus has granted the underwriters a 45-day option to purchase up to an additional 435,000 shares to cover over-allotments, if any.

Mylan sued in connection with the filing of ANDA with FDA for Armodafinil Tablets

Mylan Inc. (Nasdaq: MYL) today confirmed that it was sued by Cephalon Inc. and Cephalon France in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Armodafinil Tablets, 50 mg, 150 mg and 250 mg.

CCEI offers courses that address the needs of infant safety in a child care setting

ChildCare Education Institute is committed to developing relevant and up-to-date online coursework that enriches early childhood professionals and the care provided to children in child care settings. CCEI offers several courses that address the needs of infant safety in a child care setting.

Read more Medical News

› Verified 4 days ago

Provider NameJeffrey A Waldron
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1396793667
PECOS PAC ID: 7315928728
Enrollment ID: I20040602000026

News Archive

Study highlights health outcomes in Hispanic and Latino populations

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, released the largest and most comprehensive health and lifestyle analysis of people from a range of Hispanic/Latino origins. The data will enable individuals, communities, and policy makers to tailor better health intervention strategies.

OSU study finds that injury prevention programs are not being used in high schools

Injury prevention programs can help reduce ankle, knee and other lower extremity injuries in sports, but the programs are not being widely used in high schools, a new study from Oregon State University has found.

Ventrus prices initial public offering at $6.00 per share

Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced the pricing of its initial public offering of 2,900,000 shares at $6.00 per share. The shares are expected to begin trading tomorrow, December 17, 2010 on the Nasdaq Capital Market under the symbol "VTUS". In addition, Ventrus has granted the underwriters a 45-day option to purchase up to an additional 435,000 shares to cover over-allotments, if any.

Mylan sued in connection with the filing of ANDA with FDA for Armodafinil Tablets

Mylan Inc. (Nasdaq: MYL) today confirmed that it was sued by Cephalon Inc. and Cephalon France in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Armodafinil Tablets, 50 mg, 150 mg and 250 mg.

CCEI offers courses that address the needs of infant safety in a child care setting

ChildCare Education Institute is committed to developing relevant and up-to-date online coursework that enriches early childhood professionals and the care provided to children in child care settings. CCEI offers several courses that address the needs of infant safety in a child care setting.

Read more Medical News

› Verified 4 days ago

Provider NameCathy J Delizo
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1033260583
PECOS PAC ID: 1951483197
Enrollment ID: I20080128000425

News Archive

Study highlights health outcomes in Hispanic and Latino populations

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, released the largest and most comprehensive health and lifestyle analysis of people from a range of Hispanic/Latino origins. The data will enable individuals, communities, and policy makers to tailor better health intervention strategies.

OSU study finds that injury prevention programs are not being used in high schools

Injury prevention programs can help reduce ankle, knee and other lower extremity injuries in sports, but the programs are not being widely used in high schools, a new study from Oregon State University has found.

Ventrus prices initial public offering at $6.00 per share

Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced the pricing of its initial public offering of 2,900,000 shares at $6.00 per share. The shares are expected to begin trading tomorrow, December 17, 2010 on the Nasdaq Capital Market under the symbol "VTUS". In addition, Ventrus has granted the underwriters a 45-day option to purchase up to an additional 435,000 shares to cover over-allotments, if any.

Mylan sued in connection with the filing of ANDA with FDA for Armodafinil Tablets

Mylan Inc. (Nasdaq: MYL) today confirmed that it was sued by Cephalon Inc. and Cephalon France in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Armodafinil Tablets, 50 mg, 150 mg and 250 mg.

CCEI offers courses that address the needs of infant safety in a child care setting

ChildCare Education Institute is committed to developing relevant and up-to-date online coursework that enriches early childhood professionals and the care provided to children in child care settings. CCEI offers several courses that address the needs of infant safety in a child care setting.

Read more Medical News

› Verified 4 days ago

Provider NameMeghan E Sueltenfuss
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1083613103
PECOS PAC ID: 7113960980
Enrollment ID: I20090331000517

News Archive

Study highlights health outcomes in Hispanic and Latino populations

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, released the largest and most comprehensive health and lifestyle analysis of people from a range of Hispanic/Latino origins. The data will enable individuals, communities, and policy makers to tailor better health intervention strategies.

OSU study finds that injury prevention programs are not being used in high schools

Injury prevention programs can help reduce ankle, knee and other lower extremity injuries in sports, but the programs are not being widely used in high schools, a new study from Oregon State University has found.

Ventrus prices initial public offering at $6.00 per share

Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced the pricing of its initial public offering of 2,900,000 shares at $6.00 per share. The shares are expected to begin trading tomorrow, December 17, 2010 on the Nasdaq Capital Market under the symbol "VTUS". In addition, Ventrus has granted the underwriters a 45-day option to purchase up to an additional 435,000 shares to cover over-allotments, if any.

Mylan sued in connection with the filing of ANDA with FDA for Armodafinil Tablets

Mylan Inc. (Nasdaq: MYL) today confirmed that it was sued by Cephalon Inc. and Cephalon France in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Armodafinil Tablets, 50 mg, 150 mg and 250 mg.

CCEI offers courses that address the needs of infant safety in a child care setting

ChildCare Education Institute is committed to developing relevant and up-to-date online coursework that enriches early childhood professionals and the care provided to children in child care settings. CCEI offers several courses that address the needs of infant safety in a child care setting.

Read more Medical News

› Verified 4 days ago

Provider NameJessica E Rothfus
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1841745882
PECOS PAC ID: 6204124217
Enrollment ID: I20161006001635

News Archive

Study highlights health outcomes in Hispanic and Latino populations

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, released the largest and most comprehensive health and lifestyle analysis of people from a range of Hispanic/Latino origins. The data will enable individuals, communities, and policy makers to tailor better health intervention strategies.

OSU study finds that injury prevention programs are not being used in high schools

Injury prevention programs can help reduce ankle, knee and other lower extremity injuries in sports, but the programs are not being widely used in high schools, a new study from Oregon State University has found.

Ventrus prices initial public offering at $6.00 per share

Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced the pricing of its initial public offering of 2,900,000 shares at $6.00 per share. The shares are expected to begin trading tomorrow, December 17, 2010 on the Nasdaq Capital Market under the symbol "VTUS". In addition, Ventrus has granted the underwriters a 45-day option to purchase up to an additional 435,000 shares to cover over-allotments, if any.

Mylan sued in connection with the filing of ANDA with FDA for Armodafinil Tablets

Mylan Inc. (Nasdaq: MYL) today confirmed that it was sued by Cephalon Inc. and Cephalon France in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Armodafinil Tablets, 50 mg, 150 mg and 250 mg.

CCEI offers courses that address the needs of infant safety in a child care setting

ChildCare Education Institute is committed to developing relevant and up-to-date online coursework that enriches early childhood professionals and the care provided to children in child care settings. CCEI offers several courses that address the needs of infant safety in a child care setting.

Read more Medical News

› Verified 4 days ago

Provider NameCiara J Taylor
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1770159048
PECOS PAC ID: 4981007812
Enrollment ID: I20210729000786

News Archive

Study highlights health outcomes in Hispanic and Latino populations

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, released the largest and most comprehensive health and lifestyle analysis of people from a range of Hispanic/Latino origins. The data will enable individuals, communities, and policy makers to tailor better health intervention strategies.

OSU study finds that injury prevention programs are not being used in high schools

Injury prevention programs can help reduce ankle, knee and other lower extremity injuries in sports, but the programs are not being widely used in high schools, a new study from Oregon State University has found.

Ventrus prices initial public offering at $6.00 per share

Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced the pricing of its initial public offering of 2,900,000 shares at $6.00 per share. The shares are expected to begin trading tomorrow, December 17, 2010 on the Nasdaq Capital Market under the symbol "VTUS". In addition, Ventrus has granted the underwriters a 45-day option to purchase up to an additional 435,000 shares to cover over-allotments, if any.

Mylan sued in connection with the filing of ANDA with FDA for Armodafinil Tablets

Mylan Inc. (Nasdaq: MYL) today confirmed that it was sued by Cephalon Inc. and Cephalon France in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Armodafinil Tablets, 50 mg, 150 mg and 250 mg.

CCEI offers courses that address the needs of infant safety in a child care setting

ChildCare Education Institute is committed to developing relevant and up-to-date online coursework that enriches early childhood professionals and the care provided to children in child care settings. CCEI offers several courses that address the needs of infant safety in a child care setting.

Read more Medical News

› Verified 4 days ago

Provider NameLia Suping Buzzell
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1174295521
PECOS PAC ID: 5890184550
Enrollment ID: I20211118000576

News Archive

Study highlights health outcomes in Hispanic and Latino populations

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, released the largest and most comprehensive health and lifestyle analysis of people from a range of Hispanic/Latino origins. The data will enable individuals, communities, and policy makers to tailor better health intervention strategies.

OSU study finds that injury prevention programs are not being used in high schools

Injury prevention programs can help reduce ankle, knee and other lower extremity injuries in sports, but the programs are not being widely used in high schools, a new study from Oregon State University has found.

Ventrus prices initial public offering at $6.00 per share

Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced the pricing of its initial public offering of 2,900,000 shares at $6.00 per share. The shares are expected to begin trading tomorrow, December 17, 2010 on the Nasdaq Capital Market under the symbol "VTUS". In addition, Ventrus has granted the underwriters a 45-day option to purchase up to an additional 435,000 shares to cover over-allotments, if any.

Mylan sued in connection with the filing of ANDA with FDA for Armodafinil Tablets

Mylan Inc. (Nasdaq: MYL) today confirmed that it was sued by Cephalon Inc. and Cephalon France in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Armodafinil Tablets, 50 mg, 150 mg and 250 mg.

CCEI offers courses that address the needs of infant safety in a child care setting

ChildCare Education Institute is committed to developing relevant and up-to-date online coursework that enriches early childhood professionals and the care provided to children in child care settings. CCEI offers several courses that address the needs of infant safety in a child care setting.

Read more Medical News

› Verified 4 days ago

Provider NameCody Lozier
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1295300978
PECOS PAC ID: 2668871435
Enrollment ID: I20211201001001

News Archive

Study highlights health outcomes in Hispanic and Latino populations

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, released the largest and most comprehensive health and lifestyle analysis of people from a range of Hispanic/Latino origins. The data will enable individuals, communities, and policy makers to tailor better health intervention strategies.

OSU study finds that injury prevention programs are not being used in high schools

Injury prevention programs can help reduce ankle, knee and other lower extremity injuries in sports, but the programs are not being widely used in high schools, a new study from Oregon State University has found.

Ventrus prices initial public offering at $6.00 per share

Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced the pricing of its initial public offering of 2,900,000 shares at $6.00 per share. The shares are expected to begin trading tomorrow, December 17, 2010 on the Nasdaq Capital Market under the symbol "VTUS". In addition, Ventrus has granted the underwriters a 45-day option to purchase up to an additional 435,000 shares to cover over-allotments, if any.

Mylan sued in connection with the filing of ANDA with FDA for Armodafinil Tablets

Mylan Inc. (Nasdaq: MYL) today confirmed that it was sued by Cephalon Inc. and Cephalon France in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Armodafinil Tablets, 50 mg, 150 mg and 250 mg.

CCEI offers courses that address the needs of infant safety in a child care setting

ChildCare Education Institute is committed to developing relevant and up-to-date online coursework that enriches early childhood professionals and the care provided to children in child care settings. CCEI offers several courses that address the needs of infant safety in a child care setting.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Axis Physical Therapy Inc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Axis Physical Therapy Inc
21009 76th Ave W,
Edmonds, WA 98026-7126

Ph: (425) 672-2910
Axis Physical Therapy Inc
21009 76th Ave W,
Edmonds, WA 98026-7126

Ph: (425) 672-2910

News Archive

Study highlights health outcomes in Hispanic and Latino populations

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, released the largest and most comprehensive health and lifestyle analysis of people from a range of Hispanic/Latino origins. The data will enable individuals, communities, and policy makers to tailor better health intervention strategies.

OSU study finds that injury prevention programs are not being used in high schools

Injury prevention programs can help reduce ankle, knee and other lower extremity injuries in sports, but the programs are not being widely used in high schools, a new study from Oregon State University has found.

Ventrus prices initial public offering at $6.00 per share

Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced the pricing of its initial public offering of 2,900,000 shares at $6.00 per share. The shares are expected to begin trading tomorrow, December 17, 2010 on the Nasdaq Capital Market under the symbol "VTUS". In addition, Ventrus has granted the underwriters a 45-day option to purchase up to an additional 435,000 shares to cover over-allotments, if any.

Mylan sued in connection with the filing of ANDA with FDA for Armodafinil Tablets

Mylan Inc. (Nasdaq: MYL) today confirmed that it was sued by Cephalon Inc. and Cephalon France in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Armodafinil Tablets, 50 mg, 150 mg and 250 mg.

CCEI offers courses that address the needs of infant safety in a child care setting

ChildCare Education Institute is committed to developing relevant and up-to-date online coursework that enriches early childhood professionals and the care provided to children in child care settings. CCEI offers several courses that address the needs of infant safety in a child care setting.

Read more News

› Verified 4 days ago


Physical Therapist in Edmonds, WA

Carissa Renee Kono, PT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 21601 76th Ave W, Edmonds, WA 98026
Phone: 425-640-4145    
Lynn R Schafer, PT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 8500 200th St Sw, Edmonds, WA 98026
Phone: 425-431-3050    
Tracie H Baylor, P.T.
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 194 Sunset Ave, Edmonds, WA 98020
Phone: 425-776-3348    Fax: 425-776-3384
Julie Foerster,
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 23320 Highway 99, Edmonds, WA 98026
Phone: 425-640-5500    
Mrs. Meghan E Sueltenfuss, MSPT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 21401 72nd Ave W, Edmonds, WA 98026
Phone: 425-412-1877    Fax: 425-339-4219
Mountain2city Physical Therapy, Pllc
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 100 2nd Ave S Ste 160, Edmonds, WA 98020
Phone: 206-601-6084    
Michael John Chamberlin, P.T.
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 7315 212th St Sw, Suite 104, Edmonds, WA 98026
Phone: 425-774-3226    Fax: 425-670-1406

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.